2seventy bio, Inc.
TSVT
$4.99
$0.010.20%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -96.52% | -139.93% | 147.23% | 7.30% | 20.68% |
| Total Depreciation and Amortization | -0.18% | -1.07% | -20.46% | -30.46% | 9.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -18.27% | 103.27% | -808.97% | 104.69% | -83.37% |
| Change in Net Operating Assets | 288.54% | -60.19% | -217.25% | 115.40% | -147.07% |
| Cash from Operations | 9.81% | 54.61% | 44.74% | 34.15% | -195.63% |
| Capital Expenditure | 100.00% | 44.26% | 90.03% | 42.86% | 60.97% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | 24,331.82% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 153.03% | -216.80% | 59.41% | -54.52% | 160.46% |
| Cash from Investing | 152.99% | -152.90% | 259.26% | -54.41% | 198.31% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -94.23% | -- | -- | 52.57% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -94.23% | 316.67% | -106.22% | 52.57% | 437.33% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 124.10% | -193.99% | 381.17% | -27.22% | -179.27% |